INDIVIDUALIZING THERAPY IN PATIENT SUBPOPULATIONS INFECTED WITH HCV WHO HAVE GENOTYPE 3, CIRRHOSIS, ARE INTERFERON-INELIGIBLE/INTOLERANT, OR HAVE FAILED PREVIOUS THERAPY
- Author
- eViralHepatitis Review
- Published
- Wed 21 Jan 2015
- Episode Link
- https://shows.acast.com/eviralhepatitisreview/episodes/5fa6e85d4a2a5c52d1e331d8
Special Edition 2014, Issue 1, Part 2.
Mark S. Sulkowski, MD from Johns Hopkins University School of Medicine in Baltimore discusses patients who have genotype 3 or cirrhosis, are interferon-ineligible/intolerant, or have failed previous therapy with program director, Dr. Raymond Chung.
The post INDIVIDUALIZING THERAPY IN PATIENT SUBPOPULATIONS INFECTED WITH HCV WHO HAVE GENOTYPE 3, CIRRHOSIS, ARE INTERFERON-INELIGIBLE/INTOLERANT, OR HAVE FAILED PREVIOUS THERAPY appeared first on DKBmed Radio.
Hosted on Acast. See acast.com/privacy for more information.
